← Open Payments lookup

EMILY WITTENBERG: Open Payments

NPI 1720797657 · ONTARIO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$927 in 33 payments from 11 companies in 2025. Trend: 2023 $532 · 2024 $697 · 2025 $927

Food & beverage: $815Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$297
Otsuka America Pharmaceutical, Inc.5$186
Teva Pharmaceuticals USA, Inc.5$172
Alkermes, Inc.3$54
Vanda Pharmaceuticals Inc.2$48
Axsome Therapeutics, Inc.2$37
E.R. Squibb & Sons, L.L.C.1$32
Janssen Scientific Affairs, LLC1$32
Biogen, Inc.1$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24

Products named: INGREZZA, REXULTI, AUSTEDO XR, FANAPT, ARISTADA, Auvelity, COBENFY, INVEGA SUSTENNA.

Industry payments across OR — which companies pay providers there.